Predictive factors of long‐term follow‐up attendance in very long‐term childhood cancer survivors
Cancer · 2023
DOI: 10.1002/cncr.34944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2023. Verfasst von Agnes Dumas und 21 weiteren Autor:innen. Beteiligte Einrichtung: Université de Paris, ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research), Paris, France. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Gustave Roussy Foundation, The French Ligue Against Cancer, The "Fondation ARC.
Abstract (Originalsprache)
Background
Long‐term follow‐up (LTFU) clinics have been developed but only some childhood cancer survivors (CCS) attend long‐term follow‐up (LTFU).
Objective
To identify factors that influence LTFU attendance.
Methods
Five‐year CCS treated for a solid tumor or lymphoma in Gustave Roussy before 2000, included in the FCCSS cohort (French Childhood Cancer Survivor Study), aged >18 years and alive at the date of the LTFU Clinic opening (January 2012) were invited to a LTFU visit. Factors associated with attendance at the LTFU clinic between 2012 and 2020 were estimated using logistic regression analyses. Analyses included different types of factors: clinical (tumor characteristics, cancer treatments, late effects), medical (medical expenses were used as a proxy of survivor’s health status), social (deprivation index based on census‐tract data relating to income, educational level, proportion of blue‐collar workers, and unemployed people living in the area of residence), and spatial (distance to the LTFU clinic).
Results
Among 2341 CCS contacted (55% males, mean age at study, 45 years; SD ± 10 years; mean age at diagnosis, 6 years; SD ± 5 years), 779 (33%) attended at least one LTFU visit. Initial cancer‐related factors associated with LTFU visit attendance were: treatment with both radiotherapy and chemotherapy (odds ratio [OR], 4.02; 95% CI, 2.11–7.70), bone sarcoma (OR, 2.43; 95% CI, 1.56–3.78), central nervous system primitive tumor (OR, 1.65; 95% CI, 1.02–2.67), and autologous hematopoietic cell transplant (OR, 2.07; 95% CI, 1.34‐3.20). Late effects (OR, 1.70; 95% CI, 1.31–2.20), highest medical expenses (OR, 1.65; 95% CI, 1.22–2.22), living in the most advantaged area (OR vs. the most deprived area = 1.60; 95% CI, 1.15–2.22), and shorter distance from LTFU care center (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université de Paris, ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research), Paris, France.
- Pediatric Department, AP-HP, Antoine Béclère Hospital, Université Paris-Saclay, Clamart, France.
- INSERM Radiation Epidemiology Team, Villejuif, France.
- Department of Clinical Research, Gustave Roussy, Villejuif, France.
- Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, Villejuif, France.
- Department of Children and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
ORCID-Profile: Rodrigue Allodji, Brice Fresneau
Förderung
- The Gustave Roussy Foundation
- The French Ligue Against Cancer
- The "Fondation ARC
- The French National Research Agency
Zitieren
APA
Dumas, A., Milcent, K., Bougas, N., Bejarano-Quisoboni, D., El Fayech, C., Charreire, H., Oberlin, O., Patte, C., Allard, J., Thebault, E., Boumaraf, A., Belhout, A., Giao, V. B., Souchard, V., Jackson, A., Allodji, R., Valteau-Couanet, D., Dufour, C., Vassal, G., …, & Fresneau, B. (2023). Predictive factors of long‐term follow‐up attendance in very long‐term childhood cancer survivors. Cancer. https://doi.org/10.1002/cncr.34944
Vancouver
Dumas A, Milcent K, Bougas N, Bejarano-Quisoboni D, El Fayech C, Charreire H, et al. Predictive factors of long‐term follow‐up attendance in very long‐term childhood cancer survivors. Cancer. 2023. doi:10.1002/cncr.34944
BibTeX
@article{Dumas2023,
author = {Dumas, Agnes and Milcent, Karen and Bougas, Nicolas and Bejarano-Quisoboni, Daniel and El Fayech, Chiraz and Charreire, Hélène and Oberlin, Odile and Patte, Catherine and Allard, Julie and Thebault, Eric and Boumaraf, Amel and Belhout, Amel and Giao, Vu-Bezin and Souchard, Vincent and Jackson, Angela and Allodji, Rodrigue and Valteau-Couanet, Dominique and Dufour, Christelle and Vassal, Gilles and Haddy, Nadia and De Vathaire, Florent and Fresneau, Brice},
title = {Predictive factors of long‐term follow‐up attendance in very long‐term childhood cancer survivors},
journal = {Cancer},
year = {2023},
doi = {10.1002/cncr.34944}
}
EUVIMED